Male smokers at increased risk for osteoporosis, fractures
the ONA take:
According to a new study published online in the journal Annals of the American Thoracic Society, researchers have found that among middle-aged to elderly tobacco smokers, men were more likely than women to have osteoporosis and vertebral fractures.
For the large study, researchers from National Jewish Health and other institutions analyzed data from 3,321 current and ex-smokers aged 45 to 80 years old. Patients were eligible if they had a minimum 10 pack-year smoking history.
Results showed that 11% of participants had normal bone density, 31% had intermediate bone density, and 58% had low bone density. In addition, 37% had one or more vertebral fractures.
Researchers found that of those with low bone density and vertebral fractures, 55% and 60%, respectively, were men. Results also showed that 84% of participants of both genders with severe chronic obstructive pulmonary disease (COPD) had low-bone density.
Each additional pack-year of tobacco smoking was associated with a 0.4% increased risk of low bone density. The findings suggest that past and current smokers of both genders should be screened for osteoporosis.
Among middle-aged to elderly tobacco smokers, men were more likely than women to have osteoporosis and vertebral fractures.
Sign Up for Free e-newsletters
- Is Radioimmunotherapy a Path Forward for Melanoma?
- FDA Approves Mogamulizumab-kpkc for Rare Subtypes of Non-Hodgkin Lymphoma
- New PDL1 Inhibitors for Non-small Cell Lung Cancer: Focus on Pembrolizumab
- Intensive Chemotherapy May Not Be Effective in MDS or AML After MDS
- ASCO Endorses SIO Guideline for Integrative Therapies in Breast Cancer
- Seeking Reliable Information on Herbal Products
- NCCIH HerbList App Launched to Provide Information on Herbal Products
- Metformin Use May Improve Survival Outcomes in Bladder Cancer
- Higher Vitamin D Levels Associated With Lower Breast Cancer Risk
- Nurse-Led Program Improves Health, Financial Outcomes in Outpatient Chemotherapy
- Adhering to Cytoreductive Therapy Use May Improve Outcomes in Polycythemia Vera
- Disparities Remain in Prevalence of Cancer Screening Tests
- Hope, Gratitude, and Spirituality: What They Mean to Cancer Patients
- FDA, EU Approvals Sought for Split Dose Regimen of Daratumumab for Multiple Myeloma
- 8 Hours of Bedrest May Be Ideal After Intrathecal Chemotherapy in Hematologic Cancers
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|